India has emerged as a global powerhouse in biopharmaceutical exports, particularly with monoclonal antibodies from India leading the charge. These precision-engineered proteins target specific disease markers, revolutionizing treatments worldwide. With over 269 export shipments recorded recently to 76 countries, Indian manufacturers command 39% of U.S. imports alone, outpacing many developed nations. Companies like those partnered …
Continue reading “Why India’s Monoclonal Antibody Manufacturers Dominate Exports”